Metropolis Healthcare Limited (METROPOLIS.NS)

INR 2128.15

(-0.16%)

Market Cap (In INR)

109.1 Billion

Revenue (In INR)

12.07 Billion

Net Income (In INR)

1.27 Billion

Avg. Volume

148.3 Thousand

Currency
INR
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
1450.0-2318.3
PE
-
EPS
-
Beta Value
0.341
ISIN
INE112L01020
CUSIP
Y59774110
CIK
-
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Medical - Diagnostics & Research
CEO
Mr. Surendran Chemmenkotil
Employee Count
-
Website
https://www.metropolisindia.com
Ipo Date
2019-04-15
Details
Metropolis Healthcare Limited provides diagnostic services in India. It offers clinical laboratory testing, and profiles and support services. The company provides diagnostic services for oncology, neurology, gynecology, and nephrology, as well as various health check-up packages for men, women, senior citizens, and youth and corporates. Its tests and profiles are used for prediction, early detection, diagnostic screening, confirmation, and/or monitoring of the disease. The company also offers corporate wellness and hospital laboratory solutions, as well as clinical research services. As of March 31, 2022, it operated 171 clinical laboratories, 9,000 pick-up points, and 704 assisted referral centers. The company was founded in 1980 and is headquartered in Mumbai, India.